• 13.01.2020 – 11:43

  COMPASS Pathways

  COMPASS Pathways Granted Patent Covering Use of Its Psilocybin Formulation in Addressing Treatment-resistant Depression

  London (ots/PRNewswire) - COMPASS Pathways, a mental health care company, announced today that it has been granted US Patent No 10,519,175, relating to methods of treating drug-resistant depression with a psilocybin formulation, by the US Patent and Trademark Office. The patent covers the use of COMPASS's ...

  more

• 09.12.2019 – 17:02

  Cannamedical Pharma GmbH

  Cannamedical® provides pharmacists with CBD-kit for the formulation of medical, GMP-compliant CBD-oil

  Cologne (ots) - Cannamedical® Pharma GmbH, one of the leading cannabis distributors and supplier of one of the best-known medical Cannabis brands in Germany and the European Union, is now offering a GMP-certified kit for the formulation of pharmaceutical CBD-oils. With this formulation kit, Cannamedical® enables ...

  more

• 06.05.2019 – 16:00

  Brenntag AG

  Brenntag North America opens expanded Personal Care Application & Development Center

  Dear all, Please find attached a press release of Brenntag North America on the grand opening of its newly expanded Personal Care Application & Development Center in Allentown, Pennsylvania. The center will further support customers in the United States and Canada who face personal care formulation challenges with technical solutions and inventive ideas. For further ...

  more

• 06.05.2019 – 11:08

  Brenntag AG

  Brenntag Food & Nutrition presentation at Vitafoods Europe 2019: Show cases on market mega trends and application development know-how

  Dear all, Please find attached a press release from Brenntag Food & Nutrition on its participation in Vitafoods Europe 2019. For further information please see the press release. Please do not hesitate to contact us if you have further questions. Best regards, Hubertus Spethmann Essen, May 6, 2019 Brenntag Food & ...

  more

• 29.01.2019 – 15:37

  Kanabo Research

  Lights Out for Insomnia: New Kanabo Research Study Offers Encouraging Results

  Tel Aviv, Israel (ots/PRNewswire) - Kanabo Research is proud to present the promising results of its pre-clinical trial, which brings the company one step closer to providing a safe remedy for insomnia and other sleep disorders, without the risk of dependency or the possibility of an overdose. (Photo: ...

  more

• 26.07.2018 – 09:02

  Merck KGaA

  Merck Receives Recommendation for Approval in 21 EU Countries for the New Formulation of Euthyrox®

  Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - German Federal Institute for Drugs and Medical Devices (BfArM) recommends new formulation of Euthyrox® for approval in 21 EU countries - BfArM is acting as a representative of all 21 EU countries involved in the EU worksharing procedure Merck, a leading science and technology company, today ...

  more

• 30.04.2007 – 08:04

  Astellas Pharma Europe Limited

  Advagraf(R) Now Approved Across Europe as a Once-Daily Immunosuppressant in Organ Transplantation

  London (ots/PRNewswire) - Astellas announced today that the European Commission has approved the immunosuppressant Advagraf(R) (generic name: tacrolimus, prolonged release) for prophylaxis of transplant rejection in adult kidney or liver allograft recipients and for the treatment of allograft rejection ...

  more